AirSculpt Technologies, Inc. (NASDAQ:AIRS) Short Interest Update

AirSculpt Technologies, Inc. (NASDAQ:AIRS) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 5,073,866 shares, a growth of 32.3% from the March 15th total of 3,836,548 shares. Currently, 30.7% of the shares of the company are sold short. Based on an average daily volume of 8,905,362 shares, the short-interest ratio is currently 0.6 days.

AirSculpt Technologies Stock Up 6.5%

AirSculpt Technologies stock opened at $2.79 on Thursday. The firm has a market cap of $196.82 million, a price-to-earnings ratio of -14.68 and a beta of 2.22. AirSculpt Technologies has a 52 week low of $1.51 and a 52 week high of $12.00. The business’s 50-day moving average price is $2.34 and its 200 day moving average price is $4.12. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.58.

AirSculpt Technologies (NASDAQ:AIRS) last posted its earnings results on Tuesday, March 31st. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.05. The firm had revenue of $33.44 million for the quarter, compared to analyst estimates of $34.93 million. AirSculpt Technologies had a negative return on equity of 5.01% and a negative net margin of 7.68%.AirSculpt Technologies’s revenue for the quarter was down 14.8% compared to the same quarter last year. During the same period last year, the company earned ($0.09) earnings per share. As a group, sell-side analysts anticipate that AirSculpt Technologies will post -0.01 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently commented on AIRS. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. Wall Street Zen raised AirSculpt Technologies from a “sell” rating to a “hold” rating in a report on Sunday, April 5th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, AirSculpt Technologies has an average rating of “Reduce” and a consensus target price of $6.00.

Insider Buying and Selling at AirSculpt Technologies

In other news, major shareholder Jorey Chernett acquired 105,848 shares of the business’s stock in a transaction dated Monday, March 16th. The shares were acquired at an average cost of $2.43 per share, with a total value of $257,210.64. Following the completion of the acquisition, the insider owned 6,592,059 shares of the company’s stock, valued at approximately $16,018,703.37. This trade represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders bought 770,150 shares of company stock valued at $1,886,024 over the last quarter. 76.58% of the stock is currently owned by corporate insiders.

Institutional Trading of AirSculpt Technologies

Institutional investors have recently bought and sold shares of the business. Aristides Capital LLC acquired a new stake in AirSculpt Technologies in the fourth quarter valued at approximately $140,000. Virtu Financial LLC acquired a new stake in AirSculpt Technologies in the fourth quarter valued at approximately $30,000. Millennium Management LLC acquired a new stake in AirSculpt Technologies in the fourth quarter valued at approximately $33,000. Engineers Gate Manager LP acquired a new stake in AirSculpt Technologies in the fourth quarter valued at approximately $54,000. Finally, Aigen Investment Management LP acquired a new stake in AirSculpt Technologies in the fourth quarter valued at approximately $36,000. 91.54% of the stock is owned by institutional investors and hedge funds.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.